Table 4.
Optimal cut-off and its corresponding 5-year distant metastasis-free survival (DMFS) rates
| Factors | Cut-off | 5-year DMFS (%) | p-value |
|---|---|---|---|
| T–SUVmax | ≤8.0 (n = 35) | 89 | 0.023a |
| >8.0 (n = 38) | 69 | ||
| T–SUVmean | ≤3.2 (n = 30) | 91 | 0.035a |
| >3.2 (n = 43) | 71 | ||
| T–SUVpeak | ≤10.2 (n = 52) | 87 | 0.007a |
| >10.2 (n = 18) | 60 | ||
| N–SUVmax | ≤10.6 (n = 52) | 87 | 0.008a |
| >10.6 (n = 21) | 60 | ||
| N–SUVpeak | ≤7.7 (n = 44) | 87 | 0.032a |
| >7.7 (n = 20) | 63 | ||
| N(f)–SUVmax | ≤10.6 (n = 59) | 88 | <0.001a |
| >10.6 (n = 14) | 43 | ||
| N(f)–SUVpeak | ≤8.5 (n = 50) | 86 | <0.001a |
| >8.5 (n = 15) | 47 |
SUVmax, maximum standardized uptake value; SUVmean, mean standardized uptake value; SUVpeak, peak standardized uptake value.
p-value <0.05.